Should You Buy Progressive Stock Right Now?

Progressive (PGR) stock has underperformed the broader market and financial sector, declining 9.3% year-to-date, despite its historical strength in property and casualty underwriting with combined ratios significantly better than the industry average. A recent Q3 combined ratio jump to 100.4 was attributed to a one-time $950 million Florida policyholder credit expense, not operational weakness. While its price-to-book ratio of 3.6 remains above the financial sector average, this price weakness and improved valuation are presented as a buying opportunity for long-term investors in a well-managed insurer.

Analysis

The S&P 500 has delivered a robust 14.4% return through November 7, 2025, largely driven by technology stocks, while the financials sector has lagged with a 9% increase. Progressive (PGR) has significantly underperformed both, with its share price declining 9.3% year-to-date, including a negative reaction to its third-quarter earnings. This underperformance presents a divergence from broader market trends.

Historically, Progressive has demonstrated strong underwriting profitability, evidenced by combined ratios of 83.4 in 2023 and 84.1 in 2024, significantly outperforming the P&C industry average which ranged from 97.3 to 103.9. The recent Q3 combined ratio jump to 100.4 was primarily due to a one-time $950 million policyholder credit expense related to a Florida law, rather than a fundamental deterioration in underwriting or risk pricing. Net premiums written still increased 9% year-over-year to $6.8 billion in Q3.

Despite its P/B ratio of 3.6 remaining above the S&P 500 Financials' 2.4, this valuation represents a substantial reduction from over 6 earlier in the year. The current price weakness, coupled with Progressive's consistent operational strength and the non-recurring nature of the Q3 combined ratio impact, suggests a potential buying opportunity for long-term investors.

Key Decisions for Investors

• Investors should monitor Progressive's future combined ratios closely to confirm that the Q3 spike was an isolated event and that underwriting profitability remains strong.
• Consider initiating or increasing exposure to PGR, leveraging the current share price weakness and improved valuation (P/B of 3.6) as a potential entry point for a historically well-managed insurer.
• Evaluate the long-term implications of regulatory environments, such as the Florida law, on P&C insurers' profitability and assess Progressive's ability to adapt and maintain its competitive edge.